Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-19-023516
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-12 19:41:59
Reporting Period:
2019-09-10
Accepted Time:
2019-09-12 19:41:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1728117 Gossamer Bio Inc. GOSS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1361712 Otello Stampacchia 888 Boylston Street, Suite 1111
Boston MA 02199
Yes No Yes No
1641348 Omega Fund V Gp Manager, Ltd. 888 Boylston Street, Suite 1111
Boston MA 02199
No No Yes No
1641354 Omega Fund V, L.p. 888 Boylston Street, Suite 1111
Boston MA 02199
No No Yes No
1641355 Omega Fund V Gp, L.p. 888 Boylston Street, Suite 1111
Boston MA 02199
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-09-10 32,373 $21.00 6,899,639 No 4 S Direct
Common Stock Disposition 2019-09-11 80,403 $21.31 6,819,236 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.08 per share, inclusive.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.63 per share, inclusive.
  3. The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi (the "Omega Directors") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any. Otello Stampacchia is also a member of the issuer's board of directors.